Feature

The stock is a way to play artificial intelligence’s energy appetite.

Big companies like Compass, Rocket, and Zillow are trying to create one-stop shopping venues for home buyers.

Chase’s Sapphire Reserve is charging $795, topping the American Express Platinum card. We look at the slew of rewards premium credit cards offer.

President Donald Trump wants lower interest rates and a new Fed chair.

Republicans’ tax bill would allow some subsidies to lapse for Obamacare insurance premiums, raising costs sharply for older Americans.

The tool is highly watched and frequently misinterpreted. Here’s a complete guide.

As President Trump wavers about immigration enforcement in key industries, ICE warns employers of unauthorized workers could face civil and criminal actions.

Chase will up the annual fee for its Sapphire card and Amex could do the same for Platinum holders.

A conversation with Ulrike Hoffmann-Burchardi of UBS Global Wealth Management. Where she sees the next “transformational innovations.”

Eighty-nine percent of the 351 S&P 500 companies that used non-GAAP numbers reported adjustments that made their results look better.

The company may be small, but recent changes to its platform should help boost shares.

The energy sector is holding its own with the S&P 500, thanks to surging natural gas stocks. Oil stocks may start to catch up though.

Thirty percent of the world’s seaborne oil trade flows through the Strait of Hormuz. Iran and its proxies could block it.

The success of Circle should lead to more crypto IPOs later this year. The contenders include Gemini, Kraken, OpenSea, and Ripple.

“Going Public,” a show hosted by X, allows viewers to invest in start-ups. Two of the featured entrepreneurs have a checkered past, Barron’s found.

Treasury-bill ETFs are rapidly gaining in popularity and challenging money-market funds and bank deposits as a place for retail investors to park cash.

Across critical sectors, business owners say fear of arrest is driving both undocumented laborers—and legal immigrants—to stay away from worksites.

The price has climbed because of U.S.-China trade deal and heightened tensions between the U.S. and Iran.

The president wants a the most-favored-nation pricing model. But the U.S. drug industry is offering a host of reasons why that isn’t a good idea.

Investors, mortgage lenders, and the government all see an angle. How it ends isn’t clear.

Detentions, deportations, and workplace absences could lead to declining job growth.

Palantir sets an all-time intraday high as the stock extends its gains for a fourth consecutive day.

The trade is effectively a bet that the president won’t deliver fully on his threats, to avoid a major hit to U.S. markets or the economy.

Set a budget and make sure you’re not risking your own financial security later in life.

The multinational conglomerate has been hurt recently by slowing sales volume for its snacks.